Phys Vivas · rheumatological
Crystal Arthropathies — Viva Defence
DCE viva defence for Crystal Arthropathies.
On this page
Study tools
Target exams
Crystal Arthropathies Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Crystal Arthropathies. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
References3ShowHide
- [1]Vargas-Santos AB, Taylor WJ, Neogi T Gout Classification Criteria: Update and Implications Current rheumatology reports, 2016.PMID 27342957
- [2]Richette P, Doherty M, Pascual E et al. 2016 updated EULAR evidence-based recommendations for the management of gout Annals of the rheumatic diseases, 2017.PMID 27457514
- [3]Abhishek A, Tedeschi SK, Pascart T et al. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease Arthritis & rheumatology (Hoboken, N.J.), 2023.PMID 37494275